Page last updated: 2024-10-29

staurosporine aglycone and Neoplasms

staurosporine aglycone has been researched along with Neoplasms in 3 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahindroo, N1
Punchihewa, C1
Fujii, N1
Naik, R1
Ban, HS1
Jang, K1
Kim, I1
Xu, X1
Harmalkar, D1
Shin, SA1
Kim, M1
Kim, BK1
Park, J1
Ku, B1
Oh, S1
Won, M1
Lee, K1
Peruzzi, B1
Bottaro, DP1

Reviews

2 reviews available for staurosporine aglycone and Neoplasms

ArticleYear
Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
    Journal of medicinal chemistry, 2009, Jul-09, Volume: 52, Issue:13

    Topics: Antineoplastic Agents; Drug Discovery; Hedgehog Proteins; Humans; Neoplasms; Signal Transduction; Tr

2009
Targeting the c-Met signaling pathway in cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jun-15, Volume: 12, Issue:12

    Topics: Antineoplastic Agents; Carbazoles; Enzyme Inhibitors; Humans; Indole Alkaloids; Neoplasms; Proto-Onc

2006

Other Studies

1 other study available for staurosporine aglycone and Neoplasms

ArticleYear
Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism.
    Journal of medicinal chemistry, 2017, 10-26, Volume: 60, Issue:20

    Topics: Anilides; Animals; Cell Line, Tumor; Enzyme Inhibitors; Humans; Isoenzymes; Malate Dehydrogenase; me

2017